is ghk cu serum safe ANAIRUI Copper Peptides GHK-Cu Essential GHK-Cu Serum: What It

If you want the underlying logic explained from scratch, see the peptide reconstitution guide, the guide to how much bacteriostatic water to use, and the insulin syringe units guide

Due to its stimulatory effects on cell proliferation and angiogenesis, the same theoretical caution regarding active cancers that applies to BPC-157 is also relevant for GHK-Cu

Graf MV, Schoenenberger, GA (1987)

Actin-binding and cell-migration activity of Thymosin Beta-4 in wound-healing and cardiac-tissue models

Side-by-Side Comparison Parameter Receptors Cagrilintide AMY1R/2R/3R + CTR Semaglutide GLP-1R Tirzepatide GLP-1R + GIPR Retatrutide GLP-1R + GIPR + Glucagon-R Parameter Half-life Cagrilintide ~7-8 days Semaglutide ~7 days Tirzepatide ~5 days Retatrutide ~6 days Parameter Dosing frequency Cagrilintide Once weekly Semaglutide Once weekly Tirzepatide Once weekly Retatrutide Once weekly Parameter Max studied dose Cagrilintide 4.5 mg/week (mono) Semaglutide 2.4 mg/week Tirzepatide 15 mg/week Retatrutide 12 mg/week Parameter Peak monotherapy weight loss Cagrilintide 11.8% at 68 wk Semaglutide 14.9-17% at 68 wk Tirzepatide 22.5% at 72 wk Retatrutide ~24% at 48 wk Parameter FDA status (June 2026) Cagrilintide Investigational Semaglutide Approved (2021) Tirzepatide Approved (2023) Retatrutide Investigational Parameter HbA1c reduction (T2D) Cagrilintide ~0.9 pp mono